Intech Investment Management LLC lifted its position in shares of ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 49.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,928 shares of the medical instruments supplier’s stock after purchasing an additional 5,288 shares during the period. Intech Investment Management LLC owned 0.06% of ICU Medical worth $2,557,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in ICUI. Allworth Financial LP bought a new stake in ICU Medical in the 2nd quarter worth about $26,000. Bessemer Group Inc. increased its stake in ICU Medical by 65.8% in the 3rd quarter. Bessemer Group Inc. now owns 189 shares of the medical instruments supplier’s stock valued at $29,000 after buying an additional 75 shares during the last quarter. Hantz Financial Services Inc. increased its stake in ICU Medical by 78.4% in the 3rd quarter. Hantz Financial Services Inc. now owns 239 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 105 shares during the last quarter. Versant Capital Management Inc lifted its position in shares of ICU Medical by 26.2% during the 3rd quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier’s stock worth $50,000 after buying an additional 65 shares in the last quarter. Finally, Public Employees Retirement System of Ohio bought a new position in shares of ICU Medical during the 2nd quarter worth approximately $51,000. 96.10% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on ICUI. BTIG Research boosted their target price on ICU Medical from $170.00 to $200.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Weiss Ratings raised ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. KeyCorp increased their price target on ICU Medical from $187.00 to $189.00 and gave the company an “overweight” rating in a research report on Friday, November 6th. Wall Street Zen upgraded ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Finally, Needham & Company LLC boosted their price objective on ICU Medical from $165.00 to $187.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, ICU Medical has a consensus rating of “Moderate Buy” and an average price target of $195.20.
Check Out Our Latest Stock Report on ICU Medical
ICU Medical Price Performance
ICUI opened at $172.52 on Friday. ICU Medical, Inc. has a fifty-two week low of $113.37 and a fifty-two week high of $192.85. The firm has a 50-day moving average of $165.37 and a 200 day moving average of $150.58. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.19 and a current ratio of 2.37. The firm has a market cap of $4.31 billion, a P/E ratio of 72.18, a PEG ratio of 2.25 and a beta of 0.88.
ICU Medical (NASDAQ:ICUI – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $2.44 EPS for the quarter, topping the consensus estimate of $2.14 by $0.30. The business had revenue of $556.22 million for the quarter, compared to analyst estimates of $552.03 million. ICU Medical had a net margin of 2.76% and a return on equity of 8.40%. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.03 earnings per share. On average, research analysts expect that ICU Medical, Inc. will post 7.41 EPS for the current year.
Insider Transactions at ICU Medical
In related news, Director Elisha W. Finney sold 1,700 shares of the company’s stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $179.00, for a total value of $304,300.00. Following the transaction, the director owned 4,871 shares in the company, valued at approximately $871,909. This represents a 25.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Virginia Sanzone sold 4,856 shares of the stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $168.69, for a total value of $819,158.64. Following the transaction, the vice president directly owned 14,604 shares of the company’s stock, valued at approximately $2,463,548.76. This trade represents a 24.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,504 shares of company stock worth $1,290,608 in the last quarter. Insiders own 2.10% of the company’s stock.
ICU Medical Company Profile
ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.
Read More
- Five stocks we like better than ICU Medical
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Free Report).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
